Stryker Corporation (NYSE:SYK - Get Free Report) Director Ronda Stryker sold 550,000 shares of the business's stock in a transaction on Friday, November 6th. The stock was sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the completion of the sale, the director owned 1,701,375 shares in the company, valued at approximately $553,491,315. The trade was a 24.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Stryker Stock Down 0.1%
SYK opened at $325.69 on Tuesday. The company has a market capitalization of $123.99 billion, a PE ratio of 23.78, a price-to-earnings-growth ratio of 2.33 and a beta of 0.78. The firm has a 50-day simple moving average of $292.26 and a two-hundred day simple moving average of $323.41. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33.
Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.55 by ($0.03). Stryker had a return on equity of 23.74% and a net margin of 13.78%. The firm had revenue of $6.52 billion during the quarter, compared to the consensus estimate of $6.62 billion. During the same period last year, the firm posted $3.19 earnings per share. The company's revenue for the quarter was up 7.6% compared to the same quarter last year. Analysts forecast that Stryker Corporation will post 14.84 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on SYK shares. Royal Bank Of Canada cut their price target on Stryker from $420.00 to $375.00 and set an "outperform" rating for the company in a report on Friday, October 30th. Leerink Partners decreased their price objective on Stryker from $403.00 to $353.00 and set an "outperform" rating on the stock in a report on Friday, October 9th. BTIG Research lowered their target price on Stryker from $316.00 to $304.00 and set a "buy" rating for the company in a research report on Friday, October 30th. Jefferies Financial Group cut their target price on shares of Stryker from $440.00 to $405.00 and set a "buy" rating for the company in a report on Tuesday, September 22nd. Finally, Raymond James Financial reissued an "outperform" rating and issued a $323.00 target price (down from $370.00) on shares of Stryker in a report on Friday, October 30th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $342.19.
Read Our Latest Stock Analysis on SYK
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the business. Gables Capital Management Inc. purchased a new position in Stryker in the second quarter worth about $25,000. Kilter Group LLC purchased a new stake in Stryker during the second quarter valued at approximately $25,000. Cornerstone Financial Management LLC raised its position in Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company's stock valued at $25,000 after purchasing an additional 31 shares during the period. Highland Investment Advisors LLC purchased a new stake in Stryker during the second quarter valued at approximately $25,000. Finally, Compass Financial Management LLC bought a new stake in shares of Stryker in the 2nd quarter valued at approximately $27,000. Institutional investors own 77.09% of the company's stock.
Stryker Company Profile
(
Get Free Report)
Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.
The company's products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.
Founded in 1941 by orthopedic surgeon Dr.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
